Yechiel Engelhard
Founder of AlleRx
Greater Boston
Overview
Work Experience
Co-Founder
2024 - Current
New Venture
2024
Investor & New Ventures Founder
2020
Investor and adviser focused on early-stage healthcare technology startups, support business strategy, market positioning, product development, and growth. Served as a board member, offering governance and strategic direction. Consult institutional investors, scout and evaluate potential investments and support portfolio companies.
Seed Investor, Adviser
2023
Investing in and advising Rise, a Fintech startup focused on financial services in developing countries. Supporting founders with funding strategy, team building, and key business strategies.
Seed Investor
2023
A startup revolutionizing the hiring of healthcare professionals, providing strategic guidance on funding, product, and market strategies to drive early-stage growth and success.
Venture Advisor
2022
Redesign Health develops technologies, tools, and insights to solve healthcare solutions.
Raised $315,000,000.00 from UPMC Enterprises, Eden Global Partners, Samsung NEXT, Declaration Partners, Euclidean Capital, General Catalyst, TriplePoint Capital and CVS Health Ventures.
Angel Investor, Executive Advisor
2017
Personalized science-backed nutrition and performance platform based on blood, DNA and fitness trackers.
InsideTracker features its platform that analyzes and tracks key biochemical and physiological markers.
Raised $18,200,000.00 from BASF Venture Capital, OurCrowd, PeakBridge and Cornucopian Capital.
Co-Founder
2020
Personalised Pet-care.
Executive Strategic Advisor
2019 - 2025
Executive and board adviser for startups and public companies. Focusing on restructuring, go-to-market, product strategy and life cycle, and management disputes.
Co-founder, Board Member
2023 - 2024
Co-founded AlleRx, Inc., an innovative startup that provides B2B virtual-care treatment platforms for families and children with allergies. Initially engaged as Executive Chairman, mentoring founders and driving a strategic shift from B2C to a scalable B2B model. Fostered integration with online health systems and pharmacies to enhance allergy treatment care delivery at the clinic. Overseeing strategic direction, product development, funding efforts, and market positioning to ensure the company’s growth.
Education
Student exchange program
2001 - 2001